ANTIMICROBIAL PEPTIDES DERIVED FROM HEPATITIS B VIRUS CORE PROTEIN ARGININE-RICH DOMAIN
    1.
    发明申请
    ANTIMICROBIAL PEPTIDES DERIVED FROM HEPATITIS B VIRUS CORE PROTEIN ARGININE-RICH DOMAIN 审中-公开
    乙型肝炎病毒核蛋白衍生自丙型肝炎病毒的抗微生物肽

    公开(公告)号:WO2014124047A4

    公开(公告)日:2014-10-02

    申请号:PCT/US2014014938

    申请日:2014-02-05

    Abstract: A pharmaceutical composition for use in killing and/or inhibiting the growth and/or proliferation of a microorganism in a subject in need thereof, or for treating a subject afflicted with a microbial infection is disclosed. The composition comprises: (a) an effective amount of an isolated peptide, wherein the peptide comprises the arginine-rich carboxy-terminal region of hepatitis B virus core protein (HBc) and exhibits an antimicrobial activity; and (b) a pharmaceutically acceptable carrier. The peptide exhibits an activity against Gram-negative bacteria, Gram-positive bacteria, and/or fungi.

    Abstract translation: 公开了用于杀死和/或抑制有需要的受试者中的微生物的生长和/或增殖或用于治疗受到微生物感染的受试者的药物组合物。 所述组合物包含:(a)有效量的分离的肽,其中所述肽包含乙型肝炎病毒核心蛋白(HBc)的富含精氨酸的羧基末端区域并显示出抗微生物活性; 和(b)药学上可接受的载体。 肽表现出对革兰氏阴性细菌,革兰氏阳性菌和/或真菌的活性。

    MODIFIED ANTIMICROBIAL PEPTIDE DERIVED FROM AN ARGININE-RICH DOMAIN

    公开(公告)号:ZA201807763B

    公开(公告)日:2020-10-28

    申请号:ZA201807763

    申请日:2018-11-19

    Abstract: An antimicrobial peptide, the peptide comprising 2 to 20 variable domains, each variable domain is a sequence of 2 to 20 consecutive basic amino acids, wherein (a) the variable domains are separated from each other by a variable linker, (b) the variable linker can have 1 to 20 any amino acids other than two or more consecutive basic amino acids, and (c) the peptide has no more than 100 amino acids.

Patent Agency Ranking